Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ORMAT TECHNOLOGIES, INC. Director's Dealing 2025

Jun 24, 2025

6968_dirs_2025-06-24_11c73d5d-704d-48e4-8f93-575daafcf4a4.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ORMAT TECHNOLOGIES, INC. (ORA)
CIK: 0001296445
Period of Report: 2025-06-20

Reporting Person: SHARIR DAFNA (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-06-20 Common Stock M 1210 $76.87 Acquired 5648 Direct
2025-06-20 Common Stock D 1089 $85.36 Disposed 4559 Direct
2025-06-20 Common Stock S 121 $85.67 Disposed 4438 Direct
2025-06-20 Common Stock M 1315 $67.54 Acquired 5753 Direct
2025-06-20 Common Stock D 1035 $85.78 Disposed 4718 Direct
2025-06-20 Common Stock S 280 $85.81 Disposed 4438 Direct
2025-06-20 Common Stock S 1200 $85.5802 Disposed 3238 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-06-20 Stock Appreciation Rights (SARS) $76.87 M 1210 Disposed 2025-11-06 Common Stock (1210) Direct
2025-06-20 Stock Appreciation Rights (SARS) $67.54 M 1315 Disposed 2026-11-04 Common Stock (1315) Direct

Footnotes

F1: Represents the exercise of Stock Appreciation Rights (SARS) expiring on November 06, 2025, for which the reporting person exercised all 1,210 shares, disposed of 1,089 shares to the issuer to cover the exercise price of the SARs, and sold the remaining 121 shares acquired upon exercise in the open market on June 20, 2025. Each SAR represents the right to receive shares of ORA common stock with a value equal to the amount by which the market value of the shares in respect of which the SAR is exercised exceeds the grant price set forth in the SAR, multiplied by the number of shares in respect of which the SAR is exercised.

F2: Represents the exercise of SARS expiring on November 04, 2026, for which the reporting person exercised all 1,315 shares, disposed of 1,035 shares to the issuer to cover the exercise price of the SARs, and sold the remaining 280 shares in the open market on June 20, 2025.

F3: Represents shares of common stock sold in the open market on June 20, 2025.